Improving detection of diabetes in pregnant women
eMOM: enhanced Monitoring to Optimize Maternal Diabetes detection
This study is looking at how using continuous glucose monitors can help find gestational diabetes earlier in pregnant women by tracking their blood sugar levels from 6 to 12 weeks into their pregnancy, so they can get the care they need sooner.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10919242 on NIH RePORTER |
What this research studies
This research investigates the early detection of gestational diabetes mellitus (GDM) in pregnant women by using continuous glucose monitors (CGM) to collect glucose data from 6-12 weeks of gestation. By monitoring glucose levels at regular intervals, the study aims to identify differences in glucose dynamics between women who develop GDM and those who do not, prior to standard screening methods. The approach includes rigorous testing to understand the underlying metabolic issues related to GDM, focusing on insulin resistance and beta-cell function. This innovative methodology could lead to earlier diagnosis and better management of diabetes during pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research are healthy, non-diabetic pregnant women between 6-12 weeks of gestation.
Not a fit: Patients who are already diagnosed with gestational diabetes or have pre-existing diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and improved management of gestational diabetes, reducing risks for both mothers and their babies.
How similar studies have performed: Previous research has shown promise in using continuous glucose monitoring for diabetes management, suggesting potential success for this novel approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Merriam, Audrey — Yale University
- Study coordinator: Merriam, Audrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.